| 8/9/2012 | CVLM | Nektar Therapeutics repurchased $42.5 million of convertibles July 11
|
| 1/18/2011 | CVHYPF | Nektar Therapeutics files automatic shelf for stock, debt, preferreds
|
| 7/27/2010 | CV | Market Commentary: Gilead opens higher, comes in; Onyx, ViroPharma in trade; AGCO in line; A&P bounces around
|
| 3/5/2010 | CV | Market Commentary: Priceline trades to 101 on debut; Nektar extends gains; SandDisk retraces gains; AMD rises
|
| 3/3/2010 | CV | Market Commentary: Analyst support helps Nektar, SanDisk; Massey up with rumors; Micron, NII firm; Vedanta upsizes
|
| 9/23/2009 | CV | Market Commentary: AMR, Goodrich Petroleum gain on debuts; Gaylord Entertainment, PHH price upsized deals
|
| 9/21/2009 | CV | Market Commentary: AMR launches convertible; Amgen, MannKind, Nektar active in trade; Sonic, Kodak richen
|
| 11/6/2008 | CV | Nektar Therapeutics buys back $100 million in convertible debt
|
| 4/9/2008 | CV | Market Commentary: Convertibles mostly softer; Citigroup, WaMu ease; Exubera news hits Nektar; Virgin, Endo to price
|
| 10/18/2007 | CV | Market Commentary: CIT active but stays still; Medtronic continues slide; St. Jude down; Nektar tumbles as Pfizer pulls drug
|
| 6/13/2006 | CV | Market Commentary: Advanced Medical, Charles River, Nabors gain on volatility; Symantec flat on debut; Nektar drops outright
|
| 3/1/2006 | CV | Market Commentary: HealthSouth, ArvinMeritor deals get warm reception; Woodson says convertibles making comeback
|
| 2/10/2006 | CV | Market Commentary: Freeport-McMoran, Inco sink in metals meltdown; Level 3 gains while investors still sweet on Nektar
|
| 2/8/2006 | CV | Market Commentary: Citadel retraces some gains; Qwest flat but adds on hedge; MGI better; Oil States lower; Pier 1 prices
|
| 1/30/2006 | CV | Market Commentary: Omnicare converts plunge on raid news; new DRS issue slows down; GMAC bids lift GM
|
| 1/30/2006 | CV | Market Commentary: Omnicare converts plunge on raid news; new DRS issue slows down; GMAC bids lift GM
|
| 1/27/2006 | CV | Market Commentary: Deals from Teva, AAR draw attention to new issues; Nektar in play on product rumors; GM up
|
| 1/19/2006 | CV | Market Commentary: Advanced Micro, Cypress gain, but Intel weaker; Hutchinson prices upsized $225 million deal
|
| 11/22/2005 | CV | Market Commentary: Convertible market mostly higher; Calpine drops on court decision; GM extends losses
|
| 11/21/2005 | CV | Market Commentary: GM mixed in light trade, Ford flat, Incyte gains on Pfizer pact, but SFBC falls
|
| 11/16/2005 | CV | Market Commentary: Convertible market finds a foothold, but GM, Ford resume slide; EDO reoffered at 99
|
| 11/14/2005 | CV | Market Commentary: Convertibles market weaker, including GM, Micron Technology; EDO, The Pantry launch offers
|
| 11/4/2005 | CV | Market Commentary: Qwest, Chesapeake remain active; Celgene up, Emdeon lower; King sideways
|
| 10/28/2005 | CV | Market Commentary: Invitrogen drops, but gains on hedge; Amkor steadies after fall; Nektar weaker
|
| 10/21/2005 | CV | Market Commentary: Wyeth holds up; Ford drops, but GM bonds move higher; Schlumberger off
|
| 10/20/2005 | CV | Market Commentary: Convertibles market reverses course after strong start; Cypress pulled down; Amgen, biotechs weaker
|
| 10/13/2005 | CV | Market Commentary: Late rally lifts GM bonds, default swaps; energy drops, but Devon/Chevron bonds better; Nektar gains
|
| 9/30/2005 | CV | Market Commentary: Micron trades actively on profit news; Interpublic, Northwest add; Trizetto reoffered at 98
|
| 9/27/2005 | CV | Market Commentary: US Airways' convertible deal eyed; Nektar extends gains; but selling weighs on overall market
|
| 9/27/2005 | BTCV | Nektar greenshoe fully exercised, augmenting 3.25% convertibles offer to $315 million
|
| 9/26/2005 | CV | Market Commentary: Dick's Sporting Goods, Best Buy trade; airlines lower; General Mills' put looks likely to entice holders
|
| 9/23/2005 | CV | Market Commentary: Nektar moves up in robust trade; energy eases; airlines lift; Rite Aid stays firm
|
| 9/23/2005 | BTCV | New Issue: Nektar sells upsized $275 million seven-year convertibles to yield 3.25%, up 32.5%
|
| 9/22/2005 | CV | Market Commentary: Citi/Genworth SYNdecs close flat; Wesco, Toreador gain, but Cyberonics drops; Nektar eyed
|
| 9/21/2005 | CV | Market Commentary: Chesapeake, Devon/Chevron trade; Chiron down; Nektar launches deal; Citi/Genworth prices
|
| 9/21/2005 | CV | Nektar Therapeutics to buy back convertibles with new offering proceeds
|
| 9/21/2005 | BTCV | Nektar $200 million seven-year convertibles talked to yield 3.25%-3.75%, up 27.50%-32.50%
|
| 9/8/2005 | CV | Market Commentary: Convertibles trade mixed, with Amgen, Nabors edging up, Cypress Semiconductor down
|
| 10/27/2004 | CVHY | Nektar files $250 million shelf
|
| 6/8/2004 | CV | Market Commentary: Players taking a reality check in wake of Mandalay upset find the market discounted considerably
|
| 4/1/2004 | CV | Nektar calls 63/4% convertibles
|
| 3/30/2004 | CV | Nektar says all 3% convertibles exchanged for stock ahead of redemption
|
| 3/8/2004 | CV | Nektar Therapeutics calls 3% convertibles
|
| 1/26/2004 | CV | Nektar exchanges $9 million 3.5% convertibles for stock
|
| 11/3/2003 | CV | Nektar issues $11.71 million 3% convertibles in exchange for $17.125 million 3.5% convertibles
|
| 10/20/2003 | CV | Nektar issues $13.978 million 3% convertibles in exchange for $20.815 million 3.5% convertibles
|
| 10/10/2003 | CV | Nektar issues $33.6 million 3% convertibles in exchange for $50 million 3.5% convertibles
|
| 8/28/2003 | CV | Market Commentary: Miscellaneous scraps of convertible paper trading; action to heat up next week
|
| 7/30/2003 | CV | Nektar greenshoe exercised, raising convertibles to $110 million, buys back $20.5 million old convertibles
|
| 6/25/2003 | CV | Market Commentary: Halliburton, EDS shoot up after pricing; yield-seekers on the hunt in wake of Fed ease
|
| 6/25/2003 | CV | New Issue: Nektar sells $100 million convertible at 3.0% yield, up 29.7%
|
| 6/24/2003 | CV | Market Commentary: Demand squeeze forces new deals to wide end of ranges; Nektar sweetens
|
| 6/23/2003 | CV | Nektar $100 million convertibles talked to yield 1.75-2.25%, up 25-30%
|
| 6/23/2003 | CV | Market Commentary: Market cheapening poses double-edged sword as new paper suffers; 4 deals emerge
|
| 1/30/2003 | CV | Deutsche sees 9 biotech issues highly probable for distressed exchange
|
